Fragile X Syndrome and Molecular Testing

The Ateneo Autism Study Group (AASG) conducts the first molecular testing for Fragile X Syndrome (FXS) in the Philippines! Identifying a genetic cause for ASD may help foresee and support diagnosis to identify additional family members who could benefit from targeted treatment. Currently, there are multiple drug trials that aim to address the cellular and behavioral concerns seen in FXS, aiming to improve the developmental trajectories caused by the mutation in FMR1 gene.